Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Pulmonary Hypertension, January 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 191 articles:
HTML format


 

Single Articles

  1. ZHOU M, Li B, Chen Y, Wang A, et al
    Chest X-ray features facilitate screening for pulmonary hypertension caused by fibrosing mediastinitis.
    Ther Adv Chronic Dis. 2022;13:20406223221143245.
    PubMed    
    Abstract available

  2. BELLOTTI A, Arora S, Gustafson C, Funk I, et al
    Predictors of Post-induction Hypotension for Patients With Pulmonary Hypertension.
    Cureus. 2022;14:e31887.
    PubMed    
    Abstract available

  3. NATHAN SD, Fernandes P, Psotka M, Vitulo P, et al
    Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
    Pulm Circ. 2022;12:e12178.
    PubMed    
    Abstract available

  4. WANG S, Guo ZY, Sun XX, Yuan P, et al
    Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients.
    Front Cardiovasc Med. 2022;9:976730.
    PubMed    
    Abstract available

  5. SONSOZ MR, Atamaner O, Inan D, Kilicgedik A, et al
    A rare cause of pulmonary hypertension: Idiopathic fibrosing mediastinitis obstructing right pulmonary artery and pulmonary veins.
    Echocardiography. 2022 Dec 28. doi: 10.1111/echo.15514.
    PubMed    
    Abstract available

  6. UYAR M
    Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome.
    South Med J. 2023;116:26-32.
    PubMed    
    Abstract available

  7. WANG Y, Zhao S, Lu M
    State-of-the-Art Cardiac Magnetic Resonance in Pulmonary Hypertension: An Update on Diagnosis, Risk Stratification and Treatment.
    Trends Cardiovasc Med. 2022 Dec 24:S1050-1738(22)00146.
    PubMed    
    Abstract available

  8. MAQHFIRAH NURUL FITRI A, Elim D, Alif Sya'ban Mahfud M, Aisha Fitri Sultan N, et al
    Polymeric hydrogel forming microneedle-mediated transdermal delivery of sildenafil citrate from direct-compressed tablet reservoir for potential improvement of pulmonary hypertension therapy.
    Int J Pharm. 2022 Dec 23:122549. doi: 10.1016/j.ijpharm.2022.122549.
    PubMed    
    Abstract available

  9. MALKMUS K, Brosien M, Knoepp F, Schaffelhofer L, et al
    Deletion of classical transient receptor potential 1, 3 and 6 alters pulmonary vasoconstriction in chronic hypoxia-induced pulmonary hypertension in mice.
    Front Physiol. 2022;13:1080875.
    PubMed    
    Abstract available

  10. INGRAM D, Alamri AK, Penn BA, Mayeux JD, et al
    Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data.
    Cureus. 2022;14:e31764.
    PubMed    
    Abstract available

  11. PEREZ PENATE G, Ochoa Parra N, Domingo Morera JA, Martinez Menaca A, et al
    Evaluation of a digital health system (PAHcare) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocol.
    Front Public Health. 2022;10:954487.
    PubMed    
    Abstract available

  12. JUJO SANADA T, Manz XD, Symersky P, Pan X, et al
    Riociguat inhibits ultra-large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients.
    Pulm Circ. 2022;12:e12146.
    PubMed    
    Abstract available

  13. BARATTO C, Caravita S, Soranna D, Dewachter C, et al
    An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease.
    Pulm Circ. 2022;12:e12145.
    PubMed    
    Abstract available

  14. ZHANG V, Ganz T, Nemeth E, Umar S, et al
    Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension.
    Pulm Circ. 2022;12:e12151.
    PubMed    
    Abstract available

  15. HASAN H, Hysko K, Jack T, Dingemann J, et al
    Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis.
    Front Cardiovasc Med. 2022;9:984698.
    PubMed    
    Abstract available

  16. ZUGUROV IK, Osadchii AM, Simakova MA, Moiseeva OM, et al
    Surgical treatment of chronic thromboembolic pulmonary hypertension in combination with a left anterior descending artery myocardial bridge: A case report.
    Front Cardiovasc Med. 2022;9:1061665.
    PubMed    
    Abstract available

  17. WINTER P, Carusi A
    Professional expectations and patient expectations concerning the development of Artificial Intelligence (AI) for the early diagnosis of Pulmonary Hypertension (PH).
    J Responsib Technol. 2022;12:None.
    PubMed    
    Abstract available

  18. LIAO J, Xie SS, Deng Y, Wu DD, et al
    PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension.
    Microvasc Res. 2022 Dec 22:104471. doi: 10.1016/j.mvr.2022.104471.
    PubMed    
    Abstract available

  19. KONG J, Hardwick A, Jiang SF, Sun K, et al
    CTEPH: A Kaiser Permanente Northern California Experience.
    Thromb Res. 2023;221:130-136.
    PubMed    
    Abstract available

  20. SINGH S, Aggarwal V, Pandey UK, Sreenidhi HC, et al
    Study of left ventricular systolic dysfunction, left ventricular diastolic dysfunction and pulmonary hypertension in CKD 3b-5ND patients-A single centre cross-sectional study.
    Nefrologia (Engl Ed). 2022 Dec 21:S2013-2514(22)00183.
    PubMed    
    Abstract available

  21. CHEN J, Zhang M, Liu Y, Zhao S, et al
    Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension.
    J Mol Cell Biol. 2022 Dec 23:mjac073. doi: 10.1093.
    PubMed    
    Abstract available

  22. GONG Q, Hu Z, Jin Q, Yan Y, et al
    Identification of JPX-RABEP1 Pair as an Immune-Related Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension by Bioinformatics and Experimental Analyses.
    Int J Mol Sci. 2022;23:15559.
    PubMed    
    Abstract available

  23. KHOURY S, Beauvais A, Colas J, Saint-Martin Willer A, et al
    Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
    Biomolecules. 2022;12:1878.
    PubMed    
    Abstract available

  24. SALUJA P, Gautam N, Amisha F, Salah HM, et al
    Influence of Iron Deficiency on Clinical and Haemodynamic Parameters in Pulmonary Arterial Hypertension Cohorts.
    Heart Lung Circ. 2022;31:1594-1603.
    PubMed    
    Abstract available

  25. ASAMI M, Kanai E, Yamauchi Y, Saito Y, et al
    Positive Intrapleural Pressure with Carbon Dioxide May Limit Intraoperative Pulmonary Arterial Bleeding: Verification by Animal Model.
    Ann Thorac Cardiovasc Surg. 2022;28:403-410.
    PubMed    
    Abstract available

  26. LALITHA R, Surak A, Bitar E, Hyderi A, et al
    Fluid and electrolyte management in preterm infants with patent ductus arteriosus.
    J Neonatal Perinatal Med. 2022;15:689-697.
    PubMed    
    Abstract available

  27. LUI JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, et al
    Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.
    Cardiovasc Drugs Ther. 2023 Jan 6. doi: 10.1007/s10557-022-07420.
    PubMed    
    Abstract available

  28. HASSANPOUR H, Farhadi N, Bahadoran S, Akbari MR, et al
    Cardiac telomere attrition following changes in the expression of shelterin genes in pulmonary hypertensive chickens.
    Br Poult Sci. 2023 Jan 6. doi: 10.1080/00071668.2022.2163877.
    PubMed    
    Abstract available

  29. BUSSE AJ, Freilinger S, Eicken A, Ewert P, et al
    Healthcare status of adults with pulmonary hypertension due to congenital heart disease.
    Cardiovasc Diagn Ther. 2022;12:840-852.
    PubMed    
    Abstract available

  30. FREIBERGER A, Busse A, Ewert P, Huntgeburth M, et al
    Quality of life in adults with congenital heart disease with and without pulmonary hypertension: a comparative study.
    Cardiovasc Diagn Ther. 2022;12:758-766.
    PubMed    
    Abstract available

  31. WIETESKA-MILEK M, Kusmierczyk-Droszcz B, Ryczek R, Szmit S, et al
    Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Pol Arch Intern Med. 2023 Jan 5:16406. doi: 10.20452/pamw.16406.
    PubMed    
    Abstract available

  32. THIENEMANN F, Katoto PDMC, Azibani F, Kodogo V, et al
    Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).
    Open Forum Infect Dis. 2022;9:ofac604.
    PubMed    
    Abstract available

  33. EROUME A EGOM E, Shiwani HA, Nouthe B
    From acute SARS-CoV-2 infection to pulmonary hypertension.
    Front Physiol. 2022;13:1023758.
    PubMed    
    Abstract available

  34. SONNY S, Yuan H, Chen S, Duncan MR, et al
    GSDMD deficiency ameliorates hyperoxia-induced BPD and ROP in neonatal mice.
    Sci Rep. 2023;13:143.
    PubMed    
    Abstract available

  35. XIONG CM, Zhai ZG, Liu ZH, Wang C, et al
    [How do we respond to the newly-revised haemodynamic definitions of pulmonary hypertension].
    Zhonghua Yi Xue Za Zhi. 2023;103:73-77.
    PubMed    
    Abstract available

  36. DUBS L, Ulrich S, Lichtblau M, Opitz I, et al
    [Pulmonary Endarterectomy and Treatment for Chronic Thromboembolic Pulmonary Hypertension].
    Praxis (Bern 1994). 2023;112:28-35.
    PubMed    
    Abstract available

  37. RADCHENKO GD, Botsiuk YA, Sirenko YM
    Ventricular Function and Cardio-Ankle Vascular Index in Patients With Pulmonary Artery Hypertension.
    Vasc Health Risk Manag. 2022;18:889-904.
    PubMed    
    Abstract available

  38. KARIMI GALOUGAHI K, Zhang Y, Kienzle V, Liu CC, et al
    beta3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension.
    Physiol Rep. 2023;11:e15549.
    PubMed    
    Abstract available

  39. HUANG X, Akgun EE, Mehmood K, Zhang H, et al
    Mechanism of Hypoxia-Mediated Smooth Muscle Cell Proliferation Leading to Vascular Remodeling.
    Biomed Res Int. 2022;2022:3959845.
    PubMed    
    Abstract available

  40. HOPPER RK, van der Have O, Hollander SA, Dipchand AI, et al
    International practice heterogeneity in pre-transplant management of pulmonary hypertension related to pediatric left heart disease.
    Pediatr Transplant. 2023 Jan 2:e14461. doi: 10.1111/petr.14461.
    PubMed    
    Abstract available

  41. LIN F, Chen Y, Mo W, Zhou H, et al
    A bibliometric analysis of autophagy in lung diseases from 2012 to 2021.
    Front Immunol. 2022;13:1092575.
    PubMed    
    Abstract available

  42. SCHULZ A, Wu DM, Ishigami S, Buratto E, et al
    Outcomes of total anomalous pulmonary venous drainage repair in neonates and the impact of pulmonary hypertension on survival.
    JTCVS Open. 2022;12:335-343.
    PubMed    
    Abstract available

  43. SUBRAMANIAN AP, Bharath AP, Barthur A, Jayranganath M, et al
    Congenital portosystemic shunt with multiple splenic artery aneurysms: Reversing pulmonary hypertension and preventing aneurysm rupture.
    Ann Pediatr Cardiol. 2022;15:300-303.
    PubMed    
    Abstract available

  44. WANG J, Ni C, Yang M, Zhang X, et al
    Apply pressure-strain loop to quantify myocardial work in pulmonary hypertension: A prospective cohort study.
    Front Cardiovasc Med. 2022;9:1022987.
    PubMed    
    Abstract available

  45. AJAYI BA, Iheonye HO, Akor AA, Ododo BI, et al
    Nonspecific Interstitial Pneumonia in a 28-Year-Old Nigerian Female: Challenges in Diagnosis and Management in Resource-Constrained Setting.
    West Afr J Med. 2022;39:1316-1318.
    PubMed    
    Abstract available

  46. YAMAMOTO K, Lemay SE, Yokokawa T, Breuils-Bonnet S, et al
    DNA-Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;68:116-119.
    PubMed    


  47. KIDA T, Matsuzaki K, Yokota I, Kawase N, et al
    Latent trajectory modelling of pulmonary artery pressure in systemic sclerosis: a retrospective cohort study.
    RMD Open. 2022;8:e002673.
    PubMed    
    Abstract available

  48. BURGER CD, Wu B, Classi P, Morland K, et al
    Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension.
    J Manag Care Spec Pharm. 2023;29:101-108.
    PubMed    
    Abstract available

  49. NISHIURA N, Kitai T, Okada T, Sano M, et al
    Long-Term Clinical Outcomes in Patients With Severe Tricuspid Regurgitation.
    J Am Heart Assoc. 2023;12:e025751.
    PubMed    
    Abstract available

  50. BAJWA EK, Cislak D, Palcza J, Feng HP, et al
    Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH).
    Respir Med. 2023;206:107065.
    PubMed    
    Abstract available

  51. ALSINA-RESTOY X, Torres-Castro R, Torralba-Garcia Y, Burgos F, et al
    Does arterial oxygenation during exercise add prognostic value in pulmonary arterial hypertension?
    Respir Med. 2023;206:107070.
    PubMed    
    Abstract available

  52. PUJITHA V, Pandey NN, Arvind B, Kumar S, et al
    Idiopathic focal fibrosing mediastinitis with unilateral pulmonary arterial and venous involvement.
    J Card Surg. 2022;37:5466-5467.
    PubMed    
    Abstract available

  53. WANG X, Liu X, Liu Z, Zheng X, et al
    Preoperative pulmonary vascular resistance and neutrophil-to-lymphocyte ratio predict the demand of extracorporeal membrane oxygenation after pulmonary endarterectomy.
    J Card Surg. 2022;37:4861-4867.
    PubMed    
    Abstract available

  54. SAID SM, Braunlin EA, Berry J, Loomis A, et al
    Successful rapid staged hybrid approach for obstructed total anomalous pulmonary venous connection.
    J Card Surg. 2022;37:5501-5504.
    PubMed    
    Abstract available

  55. BOUSSEAU S, Lahm T
    Hungry for Chloride: Reprogramming Endothelial Cell Metabolism in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;68:11-12.
    PubMed    


  56. ALZAYDI MM, Abdul-Salam VB, Whitwell HJ, Russomanno G, et al
    Intracellular Chloride Channels Regulate Endothelial Metabolic Reprogramming in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;68:103-115.
    PubMed    
    Abstract available

  57. AGGARWAL V, Stapleton GE, Eilers LF, Gowda S, et al
    Pulmonary Vein Atresia: Feasibility of Initial Recanalization Attempts with Subsequent Follow-up.
    Curr Probl Cardiol. 2023;48:101463.
    PubMed    
    Abstract available

  58. KIM MS, Kim H, Seo Y, Yum SK, et al
    Non-reassuring fetal status and anesthetic impact on cesarean section-delivered very-low-birthweight infants.
    Pediatr Int. 2022;64:e15308.
    PubMed    
    Abstract available

  59. VENTETUOLO CE, Moutchia J, Baird GL, Appleby DH, et al
    Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials.
    Ann Am Thorac Soc. 2023;20:58-66.
    PubMed    
    Abstract available

  60. JEONG EM, Pereira M, So EY, Wu KQ, et al
    Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.
    Cardiovasc Res. 2022;118:3211-3224.
    PubMed    
    Abstract available

  61. RAMLY F, Mahamooth MIJ, Abidin HAZ, Hassan J, et al
    Reversible Pulmonary Hypertension in Hyperthyroid Mother: A case report and review of prior cases.
    Int J Gynaecol Obstet. 2023 Jan 13. doi: 10.1002/ijgo.14669.
    PubMed    


  62. FU L, Wang R, Zhao J, Ni Y, et al
    'Two-step' percutaneous procedure for repairing the atrial septal defect with severe pulmonary hypertension: a case report.
    J Surg Case Rep. 2023;2023:rjac612.
    PubMed    
    Abstract available

  63. KARVASARSKI E, Bentley RF, Buchan TA, Valle FH, et al
    Alterations of pulmonary vascular afterload in exercise-induced pre- and post-capillary pulmonary hypertension.
    Physiol Rep. 2023;11:e15559.
    PubMed    
    Abstract available

  64. WU Z, Zhu L, Nie X, Wei L, et al
    USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner.
    Exp Mol Med. 2023 Jan 12. doi: 10.1038/s12276-022-00920.
    PubMed    
    Abstract available

  65. LU W, Huang J, Shen Q, Sun F, et al
    Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning.
    Sci Rep. 2023;13:615.
    PubMed    
    Abstract available

  66. KRZYZEWSKA A, Baranowska-Kuczko M, Kasacka I, Kozlowska H, et al
    Cannabidiol inhibits lung proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Biomed Pharmacother. 2023;159:114234.
    PubMed    
    Abstract available

  67. LAMIA B, Dallongeville J, Bensimon L, Hakme A, et al
    Riociguat real-world use in patients with chronic thromboembolic pulmonary hypertension: A retrospective, observational cohort study in France.
    Respir Med Res. 2022;83:100987.
    PubMed    
    Abstract available

  68. HONG S, Kang X, Lio KU, LE Y, et al
    Multidisciplinary approach for the management of term pregnancy complicated by Eisenmenger syndrome.
    J Zhejiang Univ Sci B. 2023;24:89-93.
    PubMed    
    Abstract available

  69. LI D, Wang J, Fang Y, Hu Y, et al
    Impaired cell-cell communication and axon guidance because of pulmonary hypoperfusion during postnatal alveolar development.
    Respir Res. 2023;24:12.
    PubMed    
    Abstract available

  70. PALA C, Blake SM
    One Size Does Not Fit All: Congenital Diaphragmatic Hernia Management in Neonates.
    Neonatal Netw. 2023;42:45-51.
    PubMed    
    Abstract available

  71. MYRONENKO O, Foris V, Crnkovic S, Olschewski A, et al
    Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?
    Eur Respir Rev. 2023;32:220173.
    PubMed    
    Abstract available

  72. DE BELEN E, McConnell JW, Elwing JM, Paculdo D, et al
    Gaps in the Care of Pulmonary Hypertension: A Cross-Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists.
    J Am Heart Assoc. 2023 Jan 11:e026413. doi: 10.1161/JAHA.122.026413.
    PubMed    
    Abstract available

  73. CHOUVARINE P, Hysko K, Chan SY, Oliveira P, et al
    Second International Pulmonary Hypertension/Heart Failure Symposium-Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network.
    Pulm Circ. 2023;13:e12175.
    PubMed    


  74. GRIVA P, Stamatakis E, Varvarousi G, Loukeri A, et al
    The Use of Vigileo(R) Monitor in a Parturient With Severe Mitral Valve Stenosis and Severe Pulmonary Hypertension Undergoing Cesarean Section Under General Anesthesia: A Case Report and Literature Review.
    Cureus. 2022;14:e32284.
    PubMed    
    Abstract available

  75. WANG YX, Reyes-Garcia J, Di Mise A, Zheng YM, et al
    Role of ryanodine receptor 2 and FK506-binding protein 12.6 dissociation in pulmonary hypertension.
    J Gen Physiol. 2023;155:e202213100.
    PubMed    
    Abstract available

  76. LIAN TY, Zhou YP, Zhu YJ, Guo F, et al
    Reply: Homocysteine and Thrombophilia in Pulmonary Hypertension.
    JACC Asia. 2022;2:651.
    PubMed    


  77. ANDERSON JJ, Lau EM
    Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia.
    JACC Asia. 2022;2:538-546.
    PubMed    
    Abstract available

  78. SPENCE JD
    Homocysteine and Thrombophilia in Pulmonary Hypertension.
    JACC Asia. 2022;2:650-651.
    PubMed    


  79. HARTOPO AB, Anggrahini DW, Satwiko MG, Damarkusuma A, et al
    Usefulness of Combining NT-proBNP Level and Right Atrial Diameter for Simple and Early Noninvasive Detection of Pulmonary Hypertension Among Adult Patients with Atrial Septal Defect.
    Acta Med Indones. 2022;54:556-566.
    PubMed    
    Abstract available

  80. LV C, Huang Y, Liao G, Wu L, et al
    Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China.
    BMC Pregnancy Childbirth. 2023;23:16.
    PubMed    
    Abstract available

  81. LUIS CALLEJAS RUBIO J, Escobar EM, Martinez EN, de la Fuente PM, et al
    Impact of the revised hemodynamic definition of pulmonary hypertension.
    Rev Esp Cardiol (Engl Ed). 2023 Jan 6:S1885-5857(23)00014.
    PubMed    


  82. BALAKRISHNAN B, Owens B, Hayes R, Wen S, et al
    A Systematic Review of Echocardiographic Parameters for the Screening of Pulmonary Hypertension: What Are the Odds?
    Cureus. 2022;14:e32185.
    PubMed    
    Abstract available

  83. LIN C, Mi J, Zhang Y, Duan S, et al
    A nomogram prediction model for early death in patients with persistent pulmonary hypertension of the newborn.
    Front Cardiovasc Med. 2022;9:1077339.
    PubMed    
    Abstract available

  84. FRANTZ RP, Leopold JA, Hassoun PM, Hemnes AR, et al
    Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study.
    Pulm Circ. 2023;13:e12181.
    PubMed    
    Abstract available

  85. ZHOU Z, Gu Y, Zheng H, Yan C, et al
    Interventional Occlusion of Large Patent Ductus Arteriosus in Adults with Severe Pulmonary Hypertension.
    J Clin Med. 2023;12:354.
    PubMed    
    Abstract available

  86. MARCHETTA S, Verbelen T, Claessen G, Quarck R, et al
    A Comprehensive Assessment of Right Ventricular Function in Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2022;12:47.
    PubMed    
    Abstract available

  87. SWINAREW AS, Gabor J, Kusz B, Skoczynski S, et al
    Exhaled Air Metabolome Analysis for Pulmonary Arterial Hypertension Fingerprints Identification-The Preliminary Study.
    Int J Environ Res Public Health. 2022;20:503.
    PubMed    
    Abstract available

  88. CERNE JW, Pathrose A, Sarnari R, Veer M, et al
    Left Ventricular Fibrosis Assessment by Native T1, ECV, and LGE in Pulmonary Hypertension Patients.
    Diagnostics (Basel). 2022;13:71.
    PubMed    
    Abstract available

  89. CHEN Y, Zhou D, Xiong M, Xi X, et al
    Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.
    Respir Res. 2023;24:4.
    PubMed    


  90. ESCALADA-PELLITERO S, Garcia-Salido A, Clemente-Garulo D, Azorin-Cuadrillero D, et al
    Fatal Pulmonary Veno-Occlusive Disease and Systemic Juvenile Idiopathic Arthritis: Case Report and Literature Review.
    Reumatol Clin (Engl Ed). 2023;19:53-56.
    PubMed    
    Abstract available

  91. LIU C, Shi Y
    Comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
    Eur J Pediatr. 2023;182:469-470.
    PubMed    


  92. FARMAKIS IT, Keller K, Barco S, Konstantinides SV, et al
    From acute pulmonary embolism to post-pulmonary embolism sequelae.
    Vasa. 2023;52:29-37.
    PubMed    
    Abstract available

  93. WOLTER NL, Jaffe IZ
    Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease.
    Am J Physiol Cell Physiol. 2023;324:C193-C204.
    PubMed    
    Abstract available

  94. FRANCESCATO G, Capolupo I, Cerbo RM, Doni D, et al
    Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey.
    Eur J Pediatr. 2023;182:393-401.
    PubMed    
    Abstract available

  95. DE GROOT-VAN DER MOOREN MD, Scheerman BC, Rammeloo LAJ, van Wieringen H, et al
    Neonatal mortality and morbidity in Down syndrome in the time of prenatal aneuploidy testing: a retrospective cohort study.
    Eur J Pediatr. 2022 Nov 9. pii: 10.1007/s00431-022-04686.
    PubMed    
    Abstract available

  96. SCHOETTLER ML, Saldana BD, Berkenkamp L, Chonat S, et al
    Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
    Transplant Cell Ther. 2023;29:45.
    PubMed    
    Abstract available

  97. WILLCOX A, Lee NT, Nandurkar HH, Sashindranath M, et al
    CD39 in the development and progression of pulmonary arterial hypertension.
    Purinergic Signal. 2022;18:409-419.
    PubMed    
    Abstract available

  98. RENET S, Chaumais MC, Gallant-Dewavrin M, Jouet E, et al
    Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertension.
    Ann Pharm Fr. 2023;81:53-63.
    PubMed    
    Abstract available

  99. HE YF, Liu Y, Yu JH, Cheng H, et al
    Pharmacokinetics, mass balance, and metabolism of [(14)C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension.
    Acta Pharmacol Sin. 2023;44:221-233.
    PubMed    
    Abstract available

  100. TAHARA N, Sugiyama Y, Tahara A, Bekki M, et al
    Reverse remodeling of small pulmonary arteries and right ventricle in pulmonary arterial hypertension.
    J Nucl Cardiol. 2022;29:3615-3618.
    PubMed    


  101. KRISTROM K, Karlstam E, Nielsen T, Lagerqvist A, et al
    A Case of Congenital Pulmonary Vein Stenosis with Secondary Post-Capillary Pulmonary Hypertension and Left Sided Congestive Heart Failure in a Cat.
    Vet Sci. 2022;10:23.
    PubMed    
    Abstract available

  102. LUI JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, et al
    Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension.
    Cardiovasc Drugs Ther. 2023 Jan 20. doi: 10.1007/s10557-023-07431.
    PubMed    


  103. KLETZER J, Hecht S, Ramsauer S, Scharinger B, et al
    A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15.
    J Cardiovasc Dev Dis. 2023;10:22.
    PubMed    
    Abstract available

  104. SAINATHAN S, Ryan J, Said S, Mullinari L, et al
    Outcomes of heart-lung transplantation in Eisenmenger syndrome compared to primary pulmonary hypertension.
    Asian Cardiovasc Thorac Ann. 2023 Jan 19:2184923231151551.
    PubMed    
    Abstract available

  105. PARVIZI R, Bilehjani E, Mahmoudian B, Koohi A, et al
    Single-Center Experience of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: The Results from the Tabriz University Medical Sciences (TUMS) CTEPH Program.
    Thorac Cardiovasc Surg. 2023 Jan 19. doi: 10.1055/s-0042-1760204.
    PubMed    
    Abstract available

  106. SATYAMURTHY A, Poojary G, Dibben G, Padmakumar R, et al
    Exercise Training in Pulmonary Hypertension: AN UPDATED SYSTEMATIC REVIEW WITH META-ANALYSIS.
    J Cardiopulm Rehabil Prev. 2023 Jan 12. doi: 10.1097/HCR.0000000000000765.
    PubMed    
    Abstract available

  107. DEGERING J, Egenlauf B, Harutyunova S, Benjamin N, et al
    Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri((R))): a prospective, 6-months, open label, observational, non-interventional study.
    Respir Res. 2023;24:18.
    PubMed    
    Abstract available

  108. KURNIK M, Bozic H, Vindisar A, Kolar P, et al
    Pulmonary hypertension at admission predicts ICU mortality in elderly critically ill with severe COVID-19 pneumonia: retrospective cohort study.
    Cardiovasc Ultrasound. 2023;21:1.
    PubMed    
    Abstract available

  109. ZENG X, Liu Q, Rathinasabapathy A, Zha L, et al
    Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report.
    BMC Pulm Med. 2023;23:26.
    PubMed    
    Abstract available

  110. MASARONE D, Kittleson M, Pollesello P, Tedford RJ, et al
    Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
    Drugs. 2023 Jan 18. doi: 10.1007/s40265-022-01833.
    PubMed    
    Abstract available

  111. ROSENKRANZ S
    [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].
    Herz. 2023 Jan 17. doi: 10.1007/s00059-022-05155.
    PubMed    
    Abstract available

  112. VALERA RJ, Fonnegra CB, Cogollo VJ, Sarmiento-Cobos M, et al
    Impact of Rapid Weight Loss after Bariatric Surgery in Systemic Inflammatory Response and Pulmonary Hemodynamics in Severely Obese Subjects with Pulmonary Hypertension.
    J Am Coll Surg. 2023;236:365-372.
    PubMed    
    Abstract available

  113. RAMOS JG, Wieslander B, Fyrdahl A, Reiter G, et al
    Pulmonary Hypertension by Catheterization Is More Accurately Detected by Cardiovascular Magnetic Resonance 4D-Flow Than Echocardiography.
    JACC Cardiovasc Imaging. 2022 Oct 28:S1936-878X(22)00550.
    PubMed    


  114. WANG YC, Lin PL, Huang CH
    Perioperative Echocardiographic Prediction of Pulmonary Hypertension by Pulmonary Artery Acceleration Time During Cardiac Surgery with Cardiopulmonary Bypass.
    J Am Soc Echocardiogr. 2023 Jan 13:S0894-7317(23)00013.
    PubMed    


  115. TANTAWY A, El-Sherif N, Makkeyah S, Eldeen NS, et al
    Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study.
    Ann Hematol. 2023 Jan 16. doi: 10.1007/s00277-023-05099.
    PubMed    
    Abstract available

  116. ALAMRI AK, Shelburne NJ, Mayeux JD, Brittain E, et al
    Pulmonary Hypertension Association's 2022 International Conference Scientific Sessions Overview.
    Pulm Circ. 2023;13:e12182.
    PubMed    
    Abstract available

  117. ZHU R, Cheng GY, Denas G, Pengo V, et al
    Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension.
    Eur J Intern Med. 2023 Jan 13:S0953-6205(23)00017.
    PubMed    
    Abstract available

  118. OLUWOLE I, Tan JBC, DeSouza S, Hutchinson M, et al
    The association between bronchopulmonary dysplasia grade and risks of adverse neurodevelopmental outcomes among preterm infants born at less than 30 weeks of gestation.
    J Matern Fetal Neonatal Med. 2023;36:2167074.
    PubMed    
    Abstract available

  119. D'ARMINI AM, Pin M, Celentano A, Te Masiglat LJ, et al
    Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: Relationship between treated branches and outcome.
    Int J Cardiol. 2023 Jan 12:S0167-5273(23)00056.
    PubMed    
    Abstract available

  120. MORA CUESTA VM, Martinez Menaca A, Iturbe Fernandez D, Tello Mena S, et al
    Impact of the New Classification of Pulmonary Hypertension in Patients With Advanced Respiratory Disease.
    Arch Bronconeumol. 2023 Jan 6:S0300-2896(23)00004.
    PubMed    


  121. GUTIERREZ-ARIAS R, Hinojosa-Riadi J, Sandoval-Canio A, Santana-Garrido H, et al
    Effectiveness of Respiratory Muscle Training in Adults With Pulmonary Hypertension. A Systematic Review and Meta-Analysis.
    Heart Lung Circ. 2023 Jan 12:S1443-9506(22)01226.
    PubMed    
    Abstract available

  122. CHU C, Liu S, Ding J, Xu P, et al
    Swietenine Alleviates Vascular Remodeling by Enhancing Mitophagy of Pulmonary Arterial Smooth Muscle Cells in Experimental Pulmonary Hypertension.
    Can J Cardiol. 2023 Jan 11:S0828-282X(23)00005.
    PubMed    
    Abstract available

  123. TORUN A, Erdem A, Oguz M, Cinar T, et al
    Successful treatment of pulmonary hypertension with macitentan in a patient with Hermansky-Pudlak syndrome.
    Kardiol Pol. 2023 Jan 14. doi: 10.33963/KP.a2023.0012.
    PubMed    


  124. LIAO H, Zhang N, Pan L, Du J, et al
    Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis.
    Arthritis Res Ther. 2023;25:9.
    PubMed    
    Abstract available

  125. LI B, Liu X, Wang B, Liu X, et al
    QRS-T angle as a predictor of pulmonary arterial hypertension: A review.
    Medicine (Baltimore). 2023;102:e32320.
    PubMed    
    Abstract available

  126. ALMUSALLY RM
    Early recognition of pulmonary complications of sickle cell disease.
    Saudi Med J. 2023;44:10-18.
    PubMed    
    Abstract available

  127. ZENG Z, Zhou X, Zhu Y, Huang X, et al
    Kruppel-like Factor 7 inhibits proliferation and migration of pulmonary smooth muscle cells via p21 activation.
    Eur J Pharmacol. 2022;940:175473.
    PubMed    
    Abstract available

  128. DING L, Qi H, Wang Y, Zhang Z, et al
    Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms.
    Biomed Pharmacother. 2023;158:114096.
    PubMed    
    Abstract available

  129. XING C, Wang X, Pan X, Yu J, et al
    Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
    Int J Cardiol. 2023;373:118-123.
    PubMed    
    Abstract available

  130. QADUS S, Naser AY, Ofori-Asenso R, Ademi Z, et al
    Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Am J Cardiovasc Drugs. 2023;23:19-33.
    PubMed    
    Abstract available

  131. KREMER N, Rako Z, Glocker F, Tello K, et al
    Monitoring of Right Ventricular Failure With Daily Pressure Volume Loops Obtained via an Application and 3-Dimensional Echocardiography.
    Circ Heart Fail. 2022 Nov 14:e010097. doi: 10.1161/CIRCHEARTFAILURE.122.010097.
    PubMed    


  132. MAHDI N, Nadeem I, Ur Rasool M, Ul Munamm SA, et al
    Pulmonary hypertension due to pulmonary embolism secondary to COVID-19: A district general hospital experience from the UK.
    J R Coll Physicians Edinb. 2023 Jan 27:14782715231152677.
    PubMed    
    Abstract available

  133. ZHENG Y, Ma H, Yan Y, Ye P, et al
    Deficiency of filamin A in smooth muscle cells protects against hypoxia‑mediated pulmonary hypertension in mice.
    Int J Mol Med. 2023;51:22.
    PubMed    
    Abstract available

  134. DONAHOE LL, Patel S, Tole S, Zorzi AP, et al
    Osteosarcoma emboli presenting as chronic thromboembolic pulmonary hypertension in a child.
    Pediatr Hematol Oncol. 2023;40:65-69.
    PubMed    
    Abstract available

  135. MOMOSE R, Inami T, Takeuchi K, Kikuchi H, et al
    Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera.
    CJC Open. 2022;5:90-92.
    PubMed    



  136. Erratum: Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension: Erratum.
    Transplant Direct. 2023;9:e1444.
    PubMed    
    Abstract available

  137. KEEN C, Smith I, Hashmi-Greenwood M, Sage K, et al
    Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) - a cohort study.
    ERJ Open Res. 2023;9:00295-2022.
    PubMed    
    Abstract available

  138. LOUW E, Baines N, Maarman G, Osman M, et al
    The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients.
    Pulm Circ. 2023;13:e12184.
    PubMed    
    Abstract available

  139. YANG F, Wang D, Zhang X, Fan H, et al
    Novel variants of seryl-tRNA synthetase resulting in HUPRA syndrome featured in pulmonary hypertension.
    Front Cardiovasc Med. 2023;9:1058569.
    PubMed    
    Abstract available

  140. NELSON EJ, Cook E, Nelson S, Brown R, et al
    Quantifying side effects and caregiver burdens of pediatric pulmonary hypertension therapies.
    BMC Pediatr. 2023;23:43.
    PubMed    
    Abstract available

  141. LESLIE E, Gibson AL, Gonzalez Bosc LV, Mermier C, et al
    Can Maternal Exercise Prevent High-Altitude Pulmonary Hypertension in Children?
    High Alt Med Biol. 2023 Jan 25. doi: 10.1089/ham.2022.0098.
    PubMed    
    Abstract available

  142. CHIANSIRIKRAIVUTI N, Sapankaew T, Pirompanich P
    Clinical characteristics of pulmonary hypertension patients who underwent right heart catheterization in Thailand: 5-year retrospective single-centre study.
    Lung India. 2023;40:42-47.
    PubMed    
    Abstract available

  143. DIDDEN EM, Lee E, Wyckmans J, Quinn D, et al
    Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data.
    Pulm Circ. 2023;13:e12188.
    PubMed    
    Abstract available

  144. LIU X, Li X, Duan J, Zhang R, et al
    The percentage of circulating fibrocytes is associated with increased morbidity of pulmonary hypertension in patients on hemodialysis.
    Semin Dial. 2023 Jan 24. doi: 10.1111/sdi.13139.
    PubMed    
    Abstract available

  145. WANG L, Zhang W, Li C, Chen X, et al
    Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension.
    BMC Pulm Med. 2023;23:31.
    PubMed    
    Abstract available

  146. DANEVA Z, Chen YL, Ta HQ, Manchikalapudi V, et al
    Endothelial IK and SK channel activation decreases pulmonary arterial pressure and vascular remodeling in pulmonary hypertension.
    Pulm Circ. 2023;13:e12186.
    PubMed    
    Abstract available

  147. HOSNA AU, Miller D, Makhoul K, Noff N, et al
    A Case of Chronic Pulmonary Embolism Resulting in Pulmonary Hypertension and Decompensated Right Heart Failure.
    Cureus. 2022;14:e32771.
    PubMed    
    Abstract available

  148. SONG J, Su H, Cao Y
    TurboHawk plaque rotation system for chronic thromboembolic pulmonary hypertension.
    Eur Heart J Case Rep. 2023;7:ytad009.
    PubMed    


  149. BHAGWANI AR, Ali M, Piper B, Liu M, et al
    A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3.
    iScience. 2023;26:105935.
    PubMed    
    Abstract available

  150. MACDONALD A, Salehi M, Alabed S, Maiter A, et al
    Semi-automatic thresholding of RV trabeculation improves repeatability and diagnostic value in suspected pulmonary hypertension.
    Front Cardiovasc Med. 2023;9:1037385.
    PubMed    
    Abstract available

  151. KIMURA M, Kohno T, Shinya Y, Hiraide T, et al
    De-escalation of oxygen-therapy and medication in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
    Can J Cardiol. 2023 Jan 19:S0828-282X(23)00051.
    PubMed    
    Abstract available

  152. BECH-HANSSEN O, Smith JG, Astengo M, Bollano E, et al
    Pulmonary Hypertension Phenotype Can Be Identified in Heart Failure with Reduced Ejection Fraction Using Echocardiographic Assessment of Pulmonary Artery Pressure with Supportive Use of Pressure Reflection Variables.
    J Am Soc Echocardiogr. 2023 Jan 18:S0894-7317(23)00021.
    PubMed    
    Abstract available

  153. GRZESK G, Witczynska A, Weglarz M, Wolowiec L, et al
    Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension.
    Molecules. 2023;28:861.
    PubMed    
    Abstract available

  154. ALQARNI AA
    Increased Thromboxane A(2) Levels in Pulmonary Artery Smooth Muscle Cells Isolated from Patients with Chronic Obstructive Pulmonary Disease.
    Medicina (Kaunas). 2023;59:165.
    PubMed    
    Abstract available

  155. KRIVICKIENE A, Verikas D, Kreckauskiene R, Padervinskiene L, et al
    Different Causes of Functional Tricuspid Valve Regurgitation Are Linked to Differences in Tricuspid Valve and Right-Sided Heart Geometry and Function: 3D Echocardiography Study.
    Medicina (Kaunas). 2022;59:57.
    PubMed    
    Abstract available

  156. KHATTAB E, Velidakis N, Gkougkoudi E, Kadoglou NPE, et al
    Exercise-Induced Pulmonary Hypertension: A Valid Entity or Another Factor of Confusion?
    Life (Basel). 2023;13:128.
    PubMed    
    Abstract available

  157. KOIKE T, Iwata H, Chikata Y, Doi S, et al
    Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry.
    J Clin Med. 2023;12:729.
    PubMed    
    Abstract available

  158. GENECAND L, Simian G, Desponds R, Wacker J, et al
    The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model.
    J Clin Med. 2023;12:410.
    PubMed    
    Abstract available

  159. ZHENG J, Liu H, Yu M, Lin B, et al
    BMPR2 Variants Underlie Nonsyndromic Oligodontia.
    Int J Mol Sci. 2023;24:1648.
    PubMed    
    Abstract available

  160. ANHEYER D, Bugaj TJ, Ludtke R, Appelbaum S, et al
    No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials.
    Int J Mol Sci. 2023;24:1069.
    PubMed    
    Abstract available

  161. ALI MK, Tian X, Zhao L, Schimmel K, et al
    PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Cells. 2023;12:316.
    PubMed    
    Abstract available

  162. DEVALLANCE ER, Dustin CM, de Jesus DS, Ghouleh IA, et al
    Specificity Protein 1-Mediated Promotion of CXCL12 Advances Endothelial Cell Metabolism and Proliferation in Pulmonary Hypertension.
    Antioxidants (Basel). 2022;12:71.
    PubMed    
    Abstract available

  163. NEWMAN-LINDSAY S, Lakshminrusimha S, Sankaran D
    Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension.
    Children (Basel). 2022;10:5.
    PubMed    
    Abstract available

  164. ABUD KCO, Machado CM, Vilas Boas LS, Maeda NY, et al
    Respiratory viruses and postoperative hemodynamics in patients with unrestrictive congenital cardiac communications: a prospective cohort study.
    Eur J Med Res. 2023;28:38.
    PubMed    
    Abstract available

  165. SALAMA AA, Padang R, Thaden JJ, Kane CJ, et al
    Value of a Right Ventricular-Specific Longitudinal Systolic Strain Software Package in Risk Prediction in Patients with Known or Suspected Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2023 Jan 17:S0894-7317(23)00018.
    PubMed    


  166. KOLB M, Lechartier B, Aubert JD, Daccord C, et al
    [Pneumology: what's new in 2022].
    Rev Med Suisse. 2023;19.
    PubMed    
    Abstract available

  167. HODA M, Lemler M, Cory M
    Vein of Galen Aneurysmal Malformation with Anomalous Right Superior Vena Cava to the Left Atrium Leading to Atypical Clinical and Echocardiographic Findings.
    Pediatr Cardiol. 2023;44:254-259.
    PubMed    
    Abstract available

  168. DAI C, Kong B, Shuai W, Xiao Z, et al
    Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease.
    ESC Heart Fail. 2023;10:578-593.
    PubMed    
    Abstract available

  169. CHILCOTE D, Mercer-Rosa L, Wang Y, Kawut SM, et al
    Alveolar dead space fraction is not associated with early RV systolic dysfunction in pediatric ARDS.
    Pediatr Pulmonol. 2023;58:559-565.
    PubMed    
    Abstract available

  170. MARRA AM, D'Assante R, Salzano A, Iacoviello M, et al
    Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry.
    ESC Heart Fail. 2023;10:159-166.
    PubMed    
    Abstract available

  171. WANG ZH, Zhou Q
    Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
    Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202211-2134.
    PubMed    


  172. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
    Reply to: Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
    Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202212-2214.
    PubMed    


  173. RAFFAY TM, Jensen EA
    Can Intermittent Hypoxemia Help Detect Pulmonary Hypertension in High-Risk Preemies?
    Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2290.
    PubMed    


  174. ELMI-SARABI M, Jarry S, Couture EJ, Haddad F, et al
    Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients.
    Anesth Analg. 2023;136:282-294.
    PubMed    
    Abstract available

  175. BARCO S, Mavromanoli AC, Kreitner KF, Bunck AC, et al
    Pre-existing chronic thromboembolic pulmonary hypertension in acute pulmonary embolism.
    Chest. 2023 Jan 5:S0012-3692(23)00013-2. doi: 10.1016/j.chest.2022.
    PubMed    
    Abstract available

  176. ALOTAIBI M, Shao J, Pauciulo MW, Nichols WC, et al
    Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.
    Chest. 2023;163:204-215.
    PubMed    
    Abstract available

  177. CUTHBERTSON I, Morrell NW, Caruso P
    BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension.
    Circ Res. 2023;132:109-126.
    PubMed    
    Abstract available

  178. ORMISTON ML, Jankov RP, Stewart DJ
    Oh NO! Loss of PHD2 leads to "radical" changes in the lung vasculature.
    Eur Respir J. 2022;60:2201776.
    PubMed    


  179. RUBIN LJ, Naeije R
    Sotatercept for pulmonary arterial hypertension: something old and something new.
    Eur Respir J. 2023;61:2201972.
    PubMed    


  180. PRICE LC, Weatherald J
    The new 2022 pulmonary hypertension guidelines: some small steps and some giant leaps forward for evidence-based care.
    Eur Respir J. 2023;61:2202150.
    PubMed    


  181. HUMBERT M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, et al
    Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.
    Eur Respir J. 2023;61:2201347.
    PubMed    
    Abstract available

  182. ROSENKRANZ S, Pausch C, Coghlan JG, Huscher D, et al
    Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    J Heart Lung Transplant. 2023;42:102-114.
    PubMed    
    Abstract available

  183. URIEL MH, Clerkin KJ, Takeda K, Naka Y, et al
    Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    J Heart Lung Transplant. 2023;42:124-133.
    PubMed    
    Abstract available

  184. GALLARDO-VARA E, Ntokou A, Dave JM, Jovin DG, et al
    Vascular pathobiology of pulmonary hypertension.
    J Heart Lung Transplant. 2022 Dec 21:S1053-2498(22)02256.
    PubMed    
    Abstract available

  185. RICHTER MJ, Fortuni F, Alenezi F, D'Alto M, et al
    Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2022 Dec 9:S1053-2498(22)02243.
    PubMed    
    Abstract available

  186. HIRSCH K, Nolley S, Ralph DD, Zheng Y, et al
    Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;42:173-82.
    PubMed    
    Abstract available

  187. DAHIYA G, Kyvernitakis A, Elhamdani A, Begg A, et al
    Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    J Heart Lung Transplant. 2022 Oct 9:S1053-2498(22)02167.
    PubMed    
    Abstract available

  188. LIU X, Ohlrich K, McGrath DP, Cobey F, et al
    Intraoperative changes and prognostic implications of pulmonary hypertension in patients with hypertrophic obstructive cardiomyopathy undergoing surgical septal myectomy.
    J Thorac Cardiovasc Surg. 2022 Oct 6:S0022-5223(22)01045.
    PubMed    
    Abstract available

  189. KING JA, Desai A, Semple T, Nicholson AG, et al
    Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension-management challenges.
    Thorax. 2023;78:107-109.
    PubMed    
    Abstract available

  190. MCCORMACK C, Kehoe B, Cullivan S, McCaffrey N, et al
    Exploration of physical activity knowledge, preferences and support needs among pulmonary hypertension patients.
    PLoS One. 2023;18:e0277696.
    PubMed    
    Abstract available

  191. TAKIGAMI M, Nakanishi N, Tsubata H, Fukai K, et al
    Efficacy and safety of guide extension catheter in balloon pulmonary angioplasty for treatment of complex lesions in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2023;18:e0280683.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;